“영천출장안마여신”的搜索结果，显示 311-320 项，共有 13276 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy.

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial compares the effect of vinorelbine with vincristine, dactinomycin, and cyclophosphamide (VAC) followed by vinorelbine and ...

5. 多囊性肾病 - 医生与科室 - 妙佑医疗国际

   了解治疗和改变生活方式如何帮助减少该疾病造成的肾脏损伤。

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial compares the effect of vinorelbine with vincristine, dactinomycin, and cyclophosphamide (VAC) followed by vinorelbine and ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to explore various biomarkers in the post-treatment tissue of patients who have responded to cancer therapy and ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...